New drug for prostate cancer launched
A NEW fast-acting hormone treatment for advanced prostate cancer has been launched in the UK during a conference taking place in Glasgow.
The new treatment Firmagon – also known by its generic name degarelix – is injected under the skin where it blocks hormone receptors in the pituitary gland.
Prostate cancer is fuelled by the male hormone testosterone.
It has an effect almost immediately, unlike existing treatments which can take up to four weeks to reduce testosterone.
The treatment was launched at the British Association of Urological Surgeons Annual Meeting in Glasgow.
Mr John Anderson, consultant urological surgeon at the Royal Hallamshire Hospital, said: "This is an important new step for the treatment of advanced hormone-dependent prostate cancer."
Email to a friend
Print this page- Alistair Darling leads ‘No to independence’ fight over tea and biscuits
- Scottish independence: SNP flip-flops over Nato
- Scottish Independence: SNP ‘won’t be Yes campaign’s only voice’
- Today’s youth not fit to be employed, says car firm Arnold Clark
- Rangers takeover: Duff & Phelps threaten legal action against BBC
Looking for...
Featured advertisers
Jobs
Search for a job
Motors
Search for a car
Property
Search for a house
Weather for Edinburgh
Friday 25 May 2012
Today
Sunny
Temperature: 10 C to 21 C
Wind Speed: 14 mph
Wind direction: North east
Tomorrow
Sunny
Temperature: 9 C to 20 C
Wind Speed: 15 mph
Wind direction: North east
